Status:

TERMINATED

PluroGel on Wounds of Mixed Etiology

Lead Sponsor:

Medline Industries

Conditions:

Venous Ulcer

Arterial Ulcer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A randomized controlled study (RCT) to investigate the topical effectiveness of PluroGel in healing venous and mixed aetiology leg ulcers. Patients with venous and mixed aetiology leg ulcers will be i...

Detailed Description

This will be a pilot, randomized, controlled, multi-center trial to determine the effectiveness of PluroGel in the reduction of size of wounds and reduction of slough covering the wound surface compar...

Eligibility Criteria

Inclusion

  • Patients aged ≥ 18 years old
  • Patients with a non-healing venous leg ulcer or mixed aetiology ulcer.
  • Duration of wound ≥ 6 weeks ≤ 5 years
  • Wound is ≥ 1 cm2 ≤ 100cm2 no length longer than 10cm
  • Presence of at least 25% visible slough within the wound bed
  • The patient must be able to understand the study and provide written informed consent
  • No clinical signs of infection

Exclusion

  • Known hypersensitivity to any of the wound dressings or compression bandaging to be used in the trial
  • Current local or systemic antibiotics in the week prior to inclusion
  • Clinically infected wound as determined by the presence of 3 or more of the following clinical signs: perilesional erythema, pain between two dressing changes, malodorous wound, abundant exudate and oedema.
  • Prolonged treatment with immunosuppressive agents or high dose corticosteroids
  • Patients who have a current illness or condition which may interfere with wound healing in the last 30 days (carcinoma, connective tissue disease, autoimmune disease or alcohol or drug abuse)
  • Patients who have participated in a clinical trial on wound healing within the past month
  • Patients with a known history of non-adherence with medical treatment

Key Trial Info

Start Date :

January 8 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 5 2021

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT03275831

Start Date

January 8 2018

End Date

October 5 2021

Last Update

October 20 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Aneurin Bevan University Health Board

Newport, South Wales, United Kingdom, NP20 4SZ

2

Cardiff & Vale University Health Board

Cardiff, Wales, United Kingdom, CF14 4XN

PluroGel on Wounds of Mixed Etiology | DecenTrialz